Lexicon Pharmaceuticals, Inc. (LXRX)

Lexicon Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 20, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	258	373	360	587	481	441
Market Cap Growth	112.59%	3.58%	-38.56%	21.91%	9.11%	-37.30%
Enterprise Value	106	261	255	480	391	392
Last Close Price	0.71	1.53	1.91	3.94	3.42	4.15
PE Ratio	-	-	-	-	-	3.39
PS Ratio	39.76	310.10	2593.28	1968.62	20.05	1.37
PB Ratio	1.45	4.01	3.08	5.16	3.08	3.77
P/TBV Ratio	4.24	7.69	4.97	8.50	4.30	8.35
P/FCF Ratio	-	-	-	-	-	3.88
P/OCF Ratio	-	-	-	-	-	3.88
EV/Sales Ratio	20.25	216.72	1833.75	1610.51	16.31	1.22
EV/EBITDA Ratio	-	-	-	-	-	2.25
EV/EBIT Ratio	-	-	-	-	-	2.30
EV/FCF Ratio	-	-	-	-	-	3.44
Debt / Equity Ratio	0.59	1.14	0.47	0.02	0.08	2.11
Debt / EBITDA Ratio	-	-	-	-	-	1.42
Debt / FCF Ratio	-	-	-	-	-	2.17
Asset Turnover	0.02	0.01	0.00	0.00	0.08	0.92
Inventory Turnover	149.99	-	-	-	-	21.33
Quick Ratio	7.25	5.42	5.97	3.92	3.26	5.02
Current Ratio	7.45	5.60	6.08	4.02	3.37	5.17
Return on Equity (ROE)	-136.09%	-168.50%	-88.37%	-65.01%	-42.84%	286.97%
Return on Assets (ROA)	-44.16%	-50.67%	-38.03%	-31.95%	-34.85%	30.29%
Return on Capital (ROIC)	-49.80%	-57.77%	-43.69%	-38.19%	-40.63%	36.50%
Earnings Yield	-83.76%	-47.44%	-28.28%	-14.96%	-12.17%	29.51%
FCF Yield	-80.66%	-43.49%	-25.02%	-15.04%	-29.73%	25.79%
Buyback Yield / Dilution	-40.47%	-33.43%	-13.79%	-31.41%	5.06%	-10.32%
Total Shareholder Return	-40.47%	-33.43%	-13.79%	-31.41%	5.06%	-10.32%

Source: S&P Capital IQ. Standard template. Financial Sources.